SCHEMBL19601397

SCHEMBL19601397

COc1c([N+](=O)[O-])ccc(C(=O)O)c1OC(C)C

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.44
TPMT P51580 1/20 0.43
PKM P14618 1/20 0.43
ALDH1A1 P00352 1/20 0.43
AKR1C3 P42330 4/20 0.41
AKR1C2 P52895 4/20 0.41
AKR1B10 O60218 1/20 0.41
AKR1B1 P15121 1/20 0.41
AKR1C4 P17516 1/20 0.41
AKR1C1 Q04828 1/20 0.41
ABCB1 P08183 1/20 0.40
DTYMK P23919 1/20 0.40
PDK1 Q15118 1/20 0.39
MAPT P10636 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
KMT2A Q03164 2/20 0.38
CTSV O60911 1/20 0.38
CTSL P07711 1/20 0.38
CASP6 P55212 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17795680 0.93 ALDH1A1 (0.46) TSHRTPMTPKMALDH1A1AKR1C3
SCHEMBL10766611 0.88 TSHR (0.51) TSHRTPMTPKMALDH1A1AKR1C3
SCHEMBL16369648 0.84 ALDH1A1 (0.44) TSHRTPMTALDH1A1AKR1C3AKR1C2
SCHEMBL5153669 0.82 PKM (0.55) TSHRTPMTPKMALDH1A1AKR1C3
SCHEMBL27883383 0.81 SIRT6 (0.43) ALDH1A1PDK1MAPTTDP1KMT2A
SCHEMBL7706078 0.81 ALDH1A1 (0.41) TSHRALDH1A1DTYMKPDK1TDP1
SCHEMBL27840740 0.79 ALDH1A1 (0.62) ALDH1A1MAPTTDP1KMT2A
SCHEMBL16392499 0.79 AKR1C3 (0.45) ALDH1A1AKR1C3AKR1C2AKR1C1MAPT
SCHEMBL12565695 0.79 TPMT (0.51) TSHRTPMTPKMAKR1C3AKR1C2
SCHEMBL14605182 0.79 TSHR (0.61) TSHRTPMTPKMALDH1A1AKR1C3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170327458-A1 NOVEL CYSTOBACTAMIDES Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2017-11-16 US disclosed
US-20170327458-A1 NOVEL CYSTOBACTAMIDES Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2017-11-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170327458-A1 NOVEL CYSTOBACTAMIDES SLC7A11, CTH, CBS TSHR 2435/4885TPMT 322/4885PKM 1544/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.